Javascript must be enabled to continue!
Blunted Hypercapnic Respiratory Drive Response in Subjects With Late-Onset Pompe Disease
View through CrossRef
BACKGROUND:
Patients with late-onset Pompe disease develop progressive hypercapnic respiratory failure that can be disproportionate to the respiratory muscle compromise and/or thoracic restriction. Although recent studies have reported the presence of a blunted hypercapnic respiratory response in some subjects with neuromuscular disorders and chronic hypercapnia, no study has evaluated the integrity of the respiratory drive in subjects with late-onset Pompe disease. Thus, we endeavor to determine the CO
2
rebreathing response in subjects with late-onset Pompe disease.
METHODS:
Respiratory muscle strength was assessed by measuring the maximum inspiratory pressure, and the maximum expiratory pressure. The maximum inspiratory pressure reflects the strength of the diaphragm and other inspiratory muscles, whereas the maximum expiratory pressure reflects the strength of the abdominal muscles and other expiratory muscles. We studied the hypercapnic drive response (measured as the ratio of the change in airway-occlusion pressure 0.1 s after the start of inspiration and end-tidal P
CO
2
in 13 subjects with late-onset Pompe disease and 51 healthy controls.
RESULTS:
Overall inspiratory muscle strength was within normal limits or slightly diminished in the late-onset Pompe disease group. Five subjects (38.5%) were chronically hypercapnic, and 9 (69.2%) had an increased breath-holding time. Compared with controls, the change in airway-occlusion pressure 0.1 s/change in end-tidal CO
2
pressure slope (hypercapnic respiratory drive) was lower in the late-onset Pompe disease group (median 0.050 [interquartile range 0.027–0.118] vs 0.183 [0.153–0.233],
P
< .001). Nine subjects (69.2%) had a blunted change in airway-occlusion pressure 0.1 s/change in end-tidal carbon dioxide pressure slope.
CONCLUSIONS:
Subjects with late-onset Pompe disease had an impaired hypercapnic respiratory drive response. The clinical impact of this phenomenon in this subject subset deserves further investigation.
Title: Blunted Hypercapnic Respiratory Drive Response in Subjects With Late-Onset Pompe Disease
Description:
BACKGROUND:
Patients with late-onset Pompe disease develop progressive hypercapnic respiratory failure that can be disproportionate to the respiratory muscle compromise and/or thoracic restriction.
Although recent studies have reported the presence of a blunted hypercapnic respiratory response in some subjects with neuromuscular disorders and chronic hypercapnia, no study has evaluated the integrity of the respiratory drive in subjects with late-onset Pompe disease.
Thus, we endeavor to determine the CO
2
rebreathing response in subjects with late-onset Pompe disease.
METHODS:
Respiratory muscle strength was assessed by measuring the maximum inspiratory pressure, and the maximum expiratory pressure.
The maximum inspiratory pressure reflects the strength of the diaphragm and other inspiratory muscles, whereas the maximum expiratory pressure reflects the strength of the abdominal muscles and other expiratory muscles.
We studied the hypercapnic drive response (measured as the ratio of the change in airway-occlusion pressure 0.
1 s after the start of inspiration and end-tidal P
CO
2
in 13 subjects with late-onset Pompe disease and 51 healthy controls.
RESULTS:
Overall inspiratory muscle strength was within normal limits or slightly diminished in the late-onset Pompe disease group.
Five subjects (38.
5%) were chronically hypercapnic, and 9 (69.
2%) had an increased breath-holding time.
Compared with controls, the change in airway-occlusion pressure 0.
1 s/change in end-tidal CO
2
pressure slope (hypercapnic respiratory drive) was lower in the late-onset Pompe disease group (median 0.
050 [interquartile range 0.
027–0.
118] vs 0.
183 [0.
153–0.
233],
P
< .
001).
Nine subjects (69.
2%) had a blunted change in airway-occlusion pressure 0.
1 s/change in end-tidal carbon dioxide pressure slope.
CONCLUSIONS:
Subjects with late-onset Pompe disease had an impaired hypercapnic respiratory drive response.
The clinical impact of this phenomenon in this subject subset deserves further investigation.
Related Results
Simulation of the suction performance of low-pressure fuel pumps
Simulation of the suction performance of low-pressure fuel pumps
Simulation des performances d'aspiration des pompes à carburant basse pression
La pompe basse pression (BP) est un élément primordial du circuit carburant des hélic...
Histological Analysis of Phrenic Motor Neurons Pompe Disease
Histological Analysis of Phrenic Motor Neurons Pompe Disease
Pompe disease is a neuromuscular disorder resulting from mutations in the gene encoding acid α-glucosidase (GAA), an enzyme responsible for lysosomal glycogen degradation. Intraven...
Pompe disease
Pompe disease
. Pompe disease is a rare, progressive disease, the basis of which is the pathogenesis of excessive accumulation of glycogen by lysosomes due to mutation of the GAA gene and loss o...
An evaluation of noninvasive mechanical ventilation application in intensive care
An evaluation of noninvasive mechanical ventilation application in intensive care
Aims: Noninvasive mechanical ventilation (NIMV) is a positive pressure treatment applied with a mask without the need for endotracheal intubation in patients with acute and chronic...
Pilarowski–Bjornsson Syndrome with Congenital Heart Defect: A Case Report and Literature Review
Pilarowski–Bjornsson Syndrome with Congenital Heart Defect: A Case Report and Literature Review
Abstract
Introduction
Pilarowski–Bjornsson syndrome (PILBOS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous variants in chromodomain helicase DNA-b...
Ventilator-associated pneumonia (VAP) - Early and late-onset differences
Ventilator-associated pneumonia (VAP) - Early and late-onset differences
Background:
VAP guidelines recommend choosing empirical antibiotic therapy based on time of diagnosis, presence of multidrug-resistant risk factors (MDR-RF) and...
Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC)
Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC)
Abstract
Objective
The objective of this study was to investigate associations between age at SSc onset and serologic, cl...
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Abstract
Early-onset Alzheimer’s disease constitutes ∼5–10% of Alzheimer’s disease. Its clinical characteristics and biomarker profiles are not well documented. To c...

